123 related articles for article (PubMed ID: 23982716)
1. Modelling the efficiency of local versus central provision of intravenous thrombolysis after acute ischemic stroke.
McMeekin P; Gray J; Ford GA; Rodgers H; Price CI
Stroke; 2013 Nov; 44(11):3114-9. PubMed ID: 23982716
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of intravenous thrombolysis with alteplase within a 3-hour window after acute ischemic stroke.
Ehlers L; Andersen G; Clausen LB; Bech M; Kjølby M
Stroke; 2007 Jan; 38(1):85-9. PubMed ID: 17122430
[TBL] [Abstract][Full Text] [Related]
3. Direct admission to stroke centers reduces treatment delay and improves clinical outcome after intravenous thrombolysis.
Kim DH; Bae HJ; Han MK; Kim BJ; Park SS; Park TH; Lee KB; Kang K; Park JM; Ko Y; Lee SJ; Choi JC; Kim JT; Cho KH; Hong KS; Cho YJ; Kim DE; Lee J; Lee J; Oh MS; Yu KH; Lee BC; Nah HW; Cha JK
J Clin Neurosci; 2016 May; 27():74-9. PubMed ID: 26778045
[TBL] [Abstract][Full Text] [Related]
4. A citywide prehospital protocol increases access to stroke thrombolysis in Toronto.
Gladstone DJ; Rodan LH; Sahlas DJ; Lee L; Murray BJ; Ween JE; Perry JR; Chenkin J; Morrison LJ; Beck S; Black SE
Stroke; 2009 Dec; 40(12):3841-4. PubMed ID: 19875743
[TBL] [Abstract][Full Text] [Related]
5. An observational study of patient characteristics associated with the mode of admission to acute stroke services in North East, England.
Price CI; Rae V; Duckett J; Wood R; Gray J; McMeekin P; Rodgers H; Portas K; Ford GA
PLoS One; 2013; 8(10):e76997. PubMed ID: 24116195
[TBL] [Abstract][Full Text] [Related]
6. Late Hospital Arrival for Thrombolysis after Stroke in Southern Portugal: Who Is at Risk?
Sobral S; Taveira I; Seixas R; Vicente AC; Duarte J; Goes AT; Durán D; Lopes J; Rita H; Nzwalo H
J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):900-905. PubMed ID: 30606619
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke: experience from Australian stroke center.
Tan Tanny SP; Busija L; Liew D; Teo S; Davis SM; Yan B
Stroke; 2013 Aug; 44(8):2269-74. PubMed ID: 23780955
[TBL] [Abstract][Full Text] [Related]
8. Quality assurance monitoring of a citywide transportation protocol improves clinical indicators of intravenous tissue plasminogen activator therapy: a community-based, longitudinal study.
Atsumi C; Hasegawa Y; Tsumura K; Ueda T; Suzuki K; Sugiyama M; Nozaki H; Suzuki S; Nakane M; Nagashima G; Kitamura T; Nikaido H; Sasanuma J
J Stroke Cerebrovasc Dis; 2015 Jan; 24(1):183-8. PubMed ID: 25440326
[TBL] [Abstract][Full Text] [Related]
9. Clinical effectiveness and cost-effectiveness of immediate angioplasty for acute myocardial infarction: systematic review and economic evaluation.
Hartwell D; Colquitt J; Loveman E; Clegg AJ; Brodin H; Waugh N; Royle P; Davidson P; Vale L; MacKenzie L
Health Technol Assess; 2005 May; 9(17):1-99, iii-iv. PubMed ID: 15876363
[TBL] [Abstract][Full Text] [Related]
10. Impact of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on door-to-needle time.
Minnerup J; Wersching H; Ringelstein EB; Schilling M; Schäbitz WR; Wellmann J; Berger K
Stroke; 2011 Oct; 42(10):2838-43. PubMed ID: 21852612
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of optimizing acute stroke care services for thrombolysis.
Penaloza-Ramos MC; Sheppard JP; Jowett S; Barton P; Mant J; Quinn T; Mellor RM; Sims D; Sandler D; McManus RJ;
Stroke; 2014 Feb; 45(2):553-62. PubMed ID: 24385272
[TBL] [Abstract][Full Text] [Related]
12. Prehospital triage to primary stroke centers and rate of stroke thrombolysis.
Prabhakaran S; O'Neill K; Stein-Spencer L; Walter J; Alberts MJ
JAMA Neurol; 2013 Sep; 70(9):1126-32. PubMed ID: 23817961
[TBL] [Abstract][Full Text] [Related]
13. Is the Cost-Effectiveness of Stroke Thrombolysis Affected by Proportion of Stroke Mimics?
Liberman AL; Choi HJ; French DD; Prabhakaran S
Stroke; 2019 Feb; 50(2):463-468. PubMed ID: 30572813
[TBL] [Abstract][Full Text] [Related]
14. Prehospital factors determining regional variation in thrombolytic therapy in acute ischemic stroke.
Lahr MM; Vroomen PC; Luijckx GJ; van der Zee DJ; de Vos R; Buskens E
Int J Stroke; 2014 Oct; 9 Suppl A100():31-5. PubMed ID: 24373584
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs.
Sandercock P; Berge E; Dennis M; Forbes J; Hand P; Kwan J; Lewis S; Lindley R; Neilson A; Wardlaw J
Stroke; 2004 Jun; 35(6):1490-7. PubMed ID: 15105519
[TBL] [Abstract][Full Text] [Related]
16. Ten-Year Evaluation of the TOYOTA Prehospital Stroke Scale for Tissue Plasminogen Activator Intravenous Therapy in the Real World.
Suzuki J; Nakai N; Kondo N; Tsuji H; Inagaki R; Furukawa S; Iwata M; Nishida S; Ito Y
Cerebrovasc Dis; 2018; 46(3-4):184-192. PubMed ID: 30384371
[TBL] [Abstract][Full Text] [Related]
17. Systematic review of stroke thrombolysis service configuration.
Price CI; Clement F; Gray J; Donaldson C; Ford GA
Expert Rev Neurother; 2009 Feb; 9(2):211-33. PubMed ID: 19210196
[TBL] [Abstract][Full Text] [Related]
18. Potential gains and costs from increasing access to thrombolysis for acute ischemic stroke patients in New Zealand hospitals.
Te Ao B; Brown P; Fink J; Vivian M; Feigin V
Int J Stroke; 2015 Aug; 10(6):903-10. PubMed ID: 24206567
[TBL] [Abstract][Full Text] [Related]
19. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the implementation of a 24-hr stroke thrombolysis emergency treatment for patients with acute ischaemic stroke.
Zhao J; Li X; Liang Y; Zhao L; Zhang X; Liu Y
J Clin Nurs; 2018 May; 27(9-10):2161-2167. PubMed ID: 29345016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
